Verition Fund Management LLC Abbott Laboratories Transaction History

Verition Fund Management LLC

$16.5 Billion
Q2 2024

A detailed history of Verition Fund Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Verition Fund Management LLC holds 29,331 shares of ABT stock, worth $3.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,331

Previous 59,882 51.02%

Holding current value

$3.3 Million

Previous $6.81 Million 55.23%

% of portfolio

0.02%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $3.08 Million - $3.44 Million	-30,551 Reduced 51.02%	29,331 $3.05 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $4.27 Million - $4.71 Million	38,975 Added 186.42%	59,882 $6.81 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $344,165 - $421,286	3,816 Added 22.33%	20,907 $2.3 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $169,374 - $203,221	1,773 Added 11.57%	17,091 $1.66 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $1.37 Million - $1.52 Million	-13,560 Reduced 46.96%	15,318 $1.67 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $2.18 Million - $2.56 Million	22,493 Added 352.28%	28,878 $2.92 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $858,581 - $1.01 Million	-9,032 Reduced 58.58%	6,385 $701,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $135,560 - $156,954	-1,401 Reduced 8.33%	15,417 $1.49 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $878,210 - $1.06 Million	-8,604 Reduced 33.84%	16,818 $1.83 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.93 Million - $2.36 Million	16,954 Added 200.21%	25,422 $3.01 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $43,092 - $52,764	373 Added 4.61%	8,468 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $189,222 - $209,335	1,622 Added 25.06%	8,095 $956,000
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $319,274 - $375,831	3,018 Added 87.35%	6,473 $750,000
Q1 2021 May 18, 2021	SELL	$108.84 - $128.23 $825,986 - $973,137	-7,589 Reduced 68.72%	3,455 $414,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $956,550 - $1.04 Million	9,110 Added 471.04%	11,044 $1.21 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $177,231 - $215,234	1,934 New	1,934 $210,000
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $359,266 - $459,816	-4,692 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $122,436 - $179,035	1,949 Added 71.05%	4,692 $370,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $215,352 - $239,738	2,743 New	2,743 $238,000
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $1.5 Million - $1.8 Million	-24,590 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $981,050 - $1.08 Million	-17,041 Reduced 40.93%	24,590 $1.5 Million
Q1 2018 May 16, 2018	BUY	$56.27 - $63.62 $1.95 Million - $2.21 Million	34,735 Added 503.7%	41,631 $2.5 Million
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $21,525 - $23,045	401 Added 6.17%	6,896 $394,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $312,149 - $348,391	6,495	6,495 $347,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Abbott Laboratories Transaction History